Palliative Performance Scale and Survival in Patients with Cancer and Non-cancer Diagnoses Needing a Palliative Care Consultation: a Retrospective Cohort Study

Overview

Journal BMC Palliat Care

Publisher Biomed Central

Specialty Critical Care

Date 2021 May 27

PMID 34039322

Citations 13

Authors

Patcharaporn Prompantakorn

Chaisiri Angkurawaranon

Kanokporn Pinyopornpanish

Lalita Chutarattanakul

Chanchanok Aramrat

Chanapat Pateekhum

Nisachol Dejkriengkraikul

Affiliations

Soon will be listed here.

Abstract

Background: Palliative Performance Scale (PPS) has been frequently used to estimate the survival time of palliative care patients. The objective was to determine the associations between the PPS and survival time among cancer and non-cancer patients in Thailand.

Methods: This is a retrospective cohort study. All in-patient adults who received a palliative care consultation at Chiang Mai University Hospital between 1 July 2018 to 31 July 2019 were included in the study and were followed-up until 26 June 2020. The Palliative Performance Scale was assessed using the validated Thai-Palliative Performance Scale for Adults. Survival analysis was used to determine the association between the Palliative Performance Scale and survival time among cancer and non-cancer patients.

Results: Out of 407 patients, 220 were male (54.1%). There were 307 cancer patients (75.4%) and 100 non-cancer patients (24.6%). The PPS and survival time in cancer patients were significantly correlated. Cancer patients with PPS 10, 20, 30, 40-60, and 70-80% had a median survival time of 2, 6, 13, 39, and 95 days, respectively. Non-cancer patients with PPS 10, 20, and 30% had a median survival time of 8, 6, and 24 days, respectively.

Conclusions: While useful for estimating survival time for cancer patients, other factors should be taken into account in estimating the survival time for non-cancer patients.

Citing Articles

Determining timeframes to death for imminently dying patients: a retrospective cohort study.

OConnor T, Liu W, Samara J, Lewis J, Strickland K, Paterson C BMC Palliat Care. 2025; 24(1):12.

PMID: 39806353 PMC: 11727548. DOI: 10.1186/s12904-024-01637-7.

Communication issues between caregivers and patients with concealment of advanced-stage cancer: A qualitative study.

Wattanapisit S, Wattanapisit A, Laksanapiya P, Tipwong A Malays Fam Physician. 2024; 19:54.

PMID: 39386360 PMC: 11464133. DOI: 10.51866/oa.574.

Describing the characteristics and symptom profile of a group of urban patients experiencing socioeconomic inequity and receiving palliative care: a descriptive exploratory analysis.

Moore H, Bablitz C, Santos Salas A, Morris H, Sinnarajah A, Watanabe S Palliat Care Soc Pract. 2024; 18:26323524241264880.

PMID: 39099621 PMC: 11295232. DOI: 10.1177/26323524241264880.

Prognostication After Dialysis Withdrawal.

So S, Lei Li K Kidney Int Rep. 2024; 9(7):2117-2124.

PMID: 39081756 PMC: 11284357. DOI: 10.1016/j.ekir.2024.04.045.

Evaluating the Utility of the Surprise Question Among General Physicians for Appropriate Palliative Care Indication in Brazil.

Borges G, Dias C Palliat Med Rep. 2024; 5(1):261-268.

PMID: 39044763 PMC: 11262583. DOI: 10.1089/pmr.2024.0003.

References

Jansen W, Buma S, Gootjes J, Zuurmond W, Perez R, Loer S . The palliative performance scale applied in high-care residential hospice: a retrospective study. J Palliat Med. 2014; 18(1):67-70. DOI: 10.1089/jpm.2013.0645. View

Yoon S, Choi S, LeBlanc T, Suh S . Palliative Performance Scale Score at 1 Week After Palliative Care Unit Admission is More Useful for Survival Prediction in Patients With Advanced Cancer in South Korea. Am J Hosp Palliat Care. 2018; 35(9):1168-1173. DOI: 10.1177/1049909118770604. View

Quinn K, Stukel T, Stall N, Huang A, Isenberg S, Tanuseputro P . Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study. BMJ. 2020; 370:m2257. PMC: 7336238. DOI: 10.1136/bmj.m2257. View

Lau F, Downing M, Lesperance M, Karlson N, Kuziemsky C, Yang J . Using the Palliative Performance Scale to provide meaningful survival estimates. J Pain Symptom Manage. 2009; 38(1):134-44. DOI: 10.1016/j.jpainsymman.2008.05.017. View

Hum Yin Mei A, Jin W, Koh Yong Hwang M, Meng Y, Seng L, Yaw W . Value of the Palliative Performance Scale in the prognostication of advanced cancer patients in a tertiary care setting. J Palliat Med. 2013; 16(8):887-93. DOI: 10.1089/jpm.2012.0556. View

Anderson F, Downing G, Hill J, Casorso L, Lerch N . Palliative performance scale (PPS): a new tool. J Palliat Care. 1996; 12(1):5-11. View

Boyd K, Murray S . Recognising and managing key transitions in end of life care. BMJ. 2010; 341:c4863. DOI: 10.1136/bmj.c4863. View

Jang R, Caraiscos V, Swami N, Banerjee S, Mak E, Kaya E . Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract. 2014; 10(5):e335-41. DOI: 10.1200/JOP.2014.001457. View

Simmons C, McMillan D, McWilliams K, Sande T, Fearon K, Tuck S . Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. J Pain Symptom Manage. 2017; 53(5):962-970.e10. DOI: 10.1016/j.jpainsymman.2016.12.330. View

10.

Lau F, Maida V, Downing M, Lesperance M, Karlson N, Kuziemsky C . Use of the Palliative Performance Scale (PPS) for end-of-life prognostication in a palliative medicine consultation service. J Pain Symptom Manage. 2009; 37(6):965-72. DOI: 10.1016/j.jpainsymman.2008.08.003. View

11.

Weng L, Huang H, Wilkie D, Hoenig N, Suarez M, Marschke M . Predicting survival with the Palliative Performance Scale in a minority-serving hospice and palliative care program. J Pain Symptom Manage. 2008; 37(4):642-8. PMC: 2699378. DOI: 10.1016/j.jpainsymman.2008.03.023. View

12.

Venketasubramanian N, Yoon B, Pandian J, Navarro J . Stroke Epidemiology in South, East, and South-East Asia: A Review. J Stroke. 2017; 19(3):286-294. PMC: 5647629. DOI: 10.5853/jos.2017.00234. View

13.

Chan E, Wu H, Chan Y . Revisiting the Palliative Performance Scale: change in scores during disease trajectory predicts survival. Palliat Med. 2012; 27(4):367-74. DOI: 10.1177/0269216312451613. View

14.

Head B, Ritchie C, Smoot T . Prognostication in hospice care: can the palliative performance scale help?. J Palliat Med. 2005; 8(3):492-502. DOI: 10.1089/jpm.2005.8.492. View

15.

Baik D, Russell D, Jordan L, Dooley F, Bowles K, Masterson Creber R . Using the Palliative Performance Scale to Estimate Survival for Patients at the End of Life: A Systematic Review of the Literature. J Palliat Med. 2018; 21(11):1651-1661. PMC: 6211821. DOI: 10.1089/jpm.2018.0141. View

16.

Bostwick D, Wolf S, Samsa G, Bull J, Taylor Jr D, Johnson K . Comparing the Palliative Care Needs of Those With Cancer to Those With Common Non-Cancer Serious Illness. J Pain Symptom Manage. 2017; 53(6):1079-1084.e1. DOI: 10.1016/j.jpainsymman.2017.02.014. View

17.

Chewaskulyong B, Sapinun L, Downing G, Intaratat P, Lesperance M, Leautrakul S . Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2). Palliat Med. 2011; 26(8):1034-41. DOI: 10.1177/0269216311424633. View

18.

Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S . Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005; 23(25):6240-8. DOI: 10.1200/JCO.2005.06.866. View

19.

Cohen-Mansfield J, Skornick-Bouchbinder M, Brill S . Trajectories of End of Life: A Systematic Review. J Gerontol B Psychol Sci Soc Sci. 2017; 73(4):564-572. DOI: 10.1093/geronb/gbx093. View

20.

Murray S, Kendall M, Boyd K, Sheikh A . Illness trajectories and palliative care. BMJ. 2005; 330(7498):1007-11. PMC: 557152. DOI: 10.1136/bmj.330.7498.1007. View